I agree. I want to buy into PIQ as I think their products with IP are potentially huge, but the lack of a distribution plan is holding me back.
I was in the pharma/diagnostic market for 35 years, including a long period in the USA. Every time I hear about the 'direct to consumer' marketing plan I step back from the 'BUY' button. Telix cracked the US diagnostic market rapidly with a great partnership with Cardinal. IMO, that is the way to penetrate the US market. A company the size of PIQ going it alone in the USA looks far too challenging.
I would like to hear from Sonic Healthcare as to why the distribution agreement failed, or more detail on what/why milestones were not met. With the potential of the test I struggle to comprehend how a company like Sonic would not meet milestones.
As mentioned by other posts here, marketing/distribution announcements may be coming. I will be watching ready to buy when they arrive.
I agree. I want to buy into PIQ as I think their products with...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 102321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 7502 | 1 |
View Market Depth
| Last trade - 07.00am 17/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |
Day chart unavailable